Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoProgression-free survival is how long patients live before their cancer worsens. The company added...
A Novel Broad-Spectrum Antiviral with Activity Against RSV
Digital Journal· 2 days ago(NYSE Amer.:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV-387 against RSV/A2 is strong enough to have ...
How to find more information about a drug that your doctor prescribed
Medical Xpress· 6 days agoYou'd also like to know things such as how quickly the drug was approved by Health Canada, whether...
Square: Restaurant Worker Pay Jumps 66% in 7 Years
PYMNTS.com· 2 days agoLabor costs continue to weigh on restaurants, according to a new report by Square. The point-of-sale payments company’s Quarterly Restaurant Report,...
The Ultimate Ranking Of Canned Roast Beef, According To Customer Reviews
Daily Meal via Yahoo News· 4 days agoFrom pot pie to beef stew, roast beef does it all! But canned roast beef can sometimes be a bit...
Madagascar's ancient baobab forests are being restored by communities—with a little help from AI
Phys.org· 3 days agoTropical ecologist Seheno Andriantsaralaza has been researching the seed dispersal of baobab trees in Madagascar since 2009. Why are baobab trees so important in Madagascar? Baobab trees are ...
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Morningstar· 7 days agoKite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel ...
Earnings call: Bio-Path Holdings reports promising Q1 2024 results By Investing.com
Investing.com· 16 hours agoBio-Path Holdings (NASDAQ: NASDAQ:BPTH), a biotechnology company focused on developing therapeutic...
The 3 Best Bargain Stocks to Buy in May 2024
InvestorPlace· 7 days agoThere are several types of bargain stocks available to buy in the stock market. There are, of course, traditional bargain stocks with very low valuations...
Kite and Arcellx to start Phase 3 trial for myeloma therapy By Investing.com
Investing.com· 6 days agoREDWOOD CITY, Calif. & SANTA MONICA, Calif. - Kite, a GileadCompany (NASDAQ: GILD), and Arcellx,...